Treatment of HIV/AIDS: do the dilemmas only increase?

Editorial

Merle A Sande et al. JAMA. 2004.

. 2004 Jul 14;292(2):266-8.

doi: 10.1001/jama.292.2.266.

No abstract available

Comment on

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.
Saag MS, Cahn P, Raffi F, Wolff M, Pearce D, Molina JM, Powderly W, Shaw AL, Mondou E, Hinkle J, Borroto-Esoda K, Quinn JB, Barry DW, Rousseau F; FTC-301A Study Team. Saag MS, et al. JAMA. 2004 Jul 14;292(2):180-9. doi: 10.1001/jama.292.2.180. JAMA. 2004. PMID: 15249567 Clinical Trial.
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, Coakley DF, Lu B, Toole JJ, Cheng AK; 903 Study Group. Gallant JE, et al. JAMA. 2004 Jul 14;292(2):191-201. doi: 10.1001/jama.292.2.191. JAMA. 2004. PMID: 15249568 Clinical Trial.
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. Yeni PG, et al. JAMA. 2004 Jul 14;292(2):251-65. doi: 10.1001/jama.292.2.251. JAMA. 2004. PMID: 15249575